BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol. 2009;16:423-430. [PMID: 19050974 DOI: 10.1245/s10434-008-0222-6] [Cited by in Crossref: 104] [Cited by in F6Publishing: 84] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Geisel D, Lüdemann L, Keuchel T, Malinowski M, Seehofer D, Stockmann M, Hamm B, Gebauer B, Denecke T. Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI. Eur Radiol 2013;23:2555-60. [PMID: 23652847 DOI: 10.1007/s00330-013-2859-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
2 Joechle K, Moser C, Ruemmele P, Schmidt KM, Werner JM, Geissler EK, Schlitt HJ, Lang SA. ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) does not affect proliferation, apoptosis, or angiogenesis as compared to standard liver resection for colorectal liver metastases. World J Surg Oncol. 2017;15:57. [PMID: 28270160 DOI: 10.1186/s12957-017-1121-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Park C, Gwon DI, Chu HH, Kim JW, Kim JH, Ko GY. Correlation of tumor response on CT with pathologically proven necrosis in hepatocellular carcinoma treated by conventional transcatheter arterial chemoembolization: threshold value of intratumoral Lipiodol accumulation predicting tumor necrosis. Abdom Radiol (NY) 2021;46:3729-37. [PMID: 33141259 DOI: 10.1007/s00261-020-02845-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Song D, Hu M, Guo W. Liver Injury and Tumor-Inhibiting Effect of Sequential Transcatheter Arterial Chemoembolization and Portal Venous Embolization on Rabbit VX2 Liver Carcinoma. Med Sci Monit. 2017;23:1471-1476. [PMID: 28344313 DOI: 10.12659/msm.899941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Marti J, Giacca M, Alshebeeb K, Bahl S, Hua C, Horn JC, Bouayache J, Patel R, Facciuto M, Schwartz M, Florman S, Kim E, Gunasekaran G. Analysis of Preoperative Portal Vein Embolization Outcomes in Patients with Hepatocellular Carcinoma: A Single-Center Experience. Journal of Vascular and Interventional Radiology 2018;29:920-6. [DOI: 10.1016/j.jvir.2018.01.780] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
6 Beppu T, Yamamura K, Okabe H, Imai K, Hayashi H. Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma. Ann Gastroenterol Surg 2021;5:287-95. [PMID: 34095718 DOI: 10.1002/ags3.12414] [Reference Citation Analysis]
7 Chapelle T, Op de Beeck B, Roeyen G, Bracke B, Hartman V, De Greef K, Huyghe I, Van der Zijden T, Morrison S, Francque S, Ysebaert D. Measuring future liver remnant function prior to hepatectomy may guide the indication for portal vein occlusion and avoid posthepatectomy liver failure: a prospective interventional study. HPB (Oxford). 2017;19:108-117. [PMID: 27956027 DOI: 10.1016/j.hpb.2016.11.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
8 Rassam F, Olthof PB, van Lienden KP, Bennink RJ, Erdmann JI, Swijnenburg RJ, Busch OR, Besselink MG, van Gulik TM. Comparison of functional and volumetric increase of the future remnant liver and postoperative outcomes after portal vein embolization and complete or partial associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Transl Med 2020;8:436. [PMID: 32395480 DOI: 10.21037/atm.2020.03.191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Pulitano C, Crawford M, Joseph D, Aldrighetti L, Sandroussi C. Preoperative assessment of postoperative liver function: the importance of residual liver volume. J Surg Oncol. 2014;110:445-450. [PMID: 24962104 DOI: 10.1002/jso.23671] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
10 Robles R, Parrilla P, López-Conesa A, Brusadin R, de la Peña J, Fuster M, García-López JA, Hernández E. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure. Br J Surg 2014;101:1129-34; discussion 1134. [PMID: 24947768 DOI: 10.1002/bjs.9547] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 11.5] [Reference Citation Analysis]
11 Mouli SK, Goff LW. Local Arterial Therapies in the Management of Unresectable Hepatocellular Carcinoma. Curr Treat Options in Oncol 2017;18. [DOI: 10.1007/s11864-017-0509-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J, Fürst G, Topp SA. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. British Journal of Surgery 2013;100:388-94. [DOI: 10.1002/bjs.8955] [Cited by in Crossref: 113] [Cited by in F6Publishing: 112] [Article Influence: 11.3] [Reference Citation Analysis]
13 Deipolyi AR, Zhang YS, Khademhosseini A, Naidu S, Borad M, Sahin B, Mathur AK, Oklu R. Portal Vein Embolization: Impact of Chemotherapy and Genetic Mutations. J Clin Med 2017;6:E26. [PMID: 28257031 DOI: 10.3390/jcm6030026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
14 Kim D, Cornman-Homonoff J, Madoff DC. Preparing for liver surgery with "Alphabet Soup": PVE, ALPPS, TAE-PVE, LVD and RL. Hepatobiliary Surg Nutr 2020;9:136-51. [PMID: 32355673 DOI: 10.21037/hbsn.2019.09.10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Beppu T, Okabe H, Okuda K, Eguchi S, Kitahara K, Taniai N, Ueno S, Shirabe K, Ohta M, Kondo K. Portal Vein Embolization Followed by Right-Side Hemihepatectomy for Hepatocellular Carcinoma Patients: A Japanese Multi-Institutional Study. J Am Coll Surg. 2016;222:1138-1148.e2. [PMID: 27107976 DOI: 10.1016/j.jamcollsurg.2016.03.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
16 Xiao N, Yu K, Yu S, Wu J, Wang J, Shan S, Zheng S, Wang L, Wang J, Peng S. The paradigm of tumor shrinkage and rapid liver remnant hypertrophy for conversion of initially unresectable colorectal liver metastasis: a case report and literature review. World J Surg Oncol. 2017;15:148. [PMID: 28774330 DOI: 10.1186/s12957-017-1212-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Robles Campos R, Parrilla Paricio P, López Conesa A, Brusadín R, López López V, Jimeno Griñó P, Fuster Quiñonero M, García López JA, de la Peña Moral J. Una nueva técnica quirúrgica para la hepatectomía derecha extendida: torniquete en la cisura umbilical y oclusión portal derecha (ALTPS). Caso clínico. Cirugía Española 2013;91:633-7. [DOI: 10.1016/j.ciresp.2013.09.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
18 Kikuchi Y, Hiroshima Y, Matsuo K, Murakami T, Kawaguchi D, Kasahara K, Tanaka K. Impact of associating liver partition and portal vein occlusion for staged hepatectomy on tumor growth in a mouse model of liver metastasis. European Journal of Surgical Oncology 2018;44:130-8. [DOI: 10.1016/j.ejso.2017.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 van Lienden KP, van den Esschert JW, Rietkerk M, Heger M, Roelofs JJ, Lameris JS, van Gulik TM. Short-term effects of combined hepatic vein embolization and portal vein embolization for the induction of liver regeneration in a rabbit model. J Vasc Interv Radiol 2012;23:962-7. [PMID: 22633622 DOI: 10.1016/j.jvir.2012.03.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
20 Treska V, Skalicky T, Sutnar A, Vaclav L, Fichtl J, Kinkorova J, Vachtova M, Narsanska A. Prognostic importance of some clinical and therapeutic factors for the effect of portal vein embolization in patients with primarily inoperable colorectal liver metastases. Arch Med Sci. 2013;9:47-54. [PMID: 23515176 DOI: 10.5114/aoms.2013.33348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
21 Bretagnol F, Maggiori L, Zappa M, Sibert A, Vilgrain V, Panis Y. Selective Portal Vein Embolization and Colorectal Liver Metastases in Rat: A New Experimental Model for Tumor Growth Study. Journal of Surgical Research 2011;171:669-74. [DOI: 10.1016/j.jss.2010.03.047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
22 Toledo RA, Cubillo A, Vega E, Garralda E, Alvarez R, de la Varga LU, Pascual JR, Sánchez G, Sarno F, Prieto SH, Perea S, Lopéz-Casas PP, López-Ríos F, Hidalgo M. Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab. Oncotarget 2017;8:35289-300. [PMID: 27852040 DOI: 10.18632/oncotarget.13311] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
23 Chan KS, Low JK, Shelat VG. Associated liver partition and portal vein ligation for staged hepatectomy: a review. Transl Gastroenterol Hepatol 2020;5:37. [PMID: 32632388 DOI: 10.21037/tgh.2019.12.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 El Bacha H, Salihoun M, Kabbaj N, Benkabbou A. Complete necrosis of hepatocellular carcinoma after preoperative portal vein embolization: a case report. J Med Case Rep 2017;11:7. [PMID: 28049508 DOI: 10.1186/s13256-016-1160-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
25 Zhang TT, Zhao XQ, Liu Z, Mao ZY, Bai L. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients. Clin Transl Oncol. 2016;18:831-840. [PMID: 26577107 DOI: 10.1007/s12094-015-1446-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
26 Malinowski M, Geisel D, Stary V, Denecke T, Seehofer D, Jara M, Baron A, Pratschke J, Gebauer B, Stockmann M. Portal vein embolization with plug/coils improves hepatectomy outcome. J Surg Res. 2015;194:202-211. [PMID: 25454977 DOI: 10.1016/j.jss.2014.10.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
27 Kis B, El-Haddad G, Sheth RA, Parikh NS, Ganguli S, Shyn PB, Choi J, Brown KT. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control 2017;24:1073274817729244. [PMID: 28975829 DOI: 10.1177/1073274817729244] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
28 Peng PD, Hyder O, Bloomston M, Marques H, Corona-Villalobos C, Dixon E, Pulitano C, Hirose K, Schulick RD, Barroso E. Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies. HPB (Oxford). 2012;14:523-531. [PMID: 22762400 DOI: 10.1111/j.1477-2574.2012.00492.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
29 Russolillo N, Langella S, Perotti S, Balbo Mussetto A, Lo Tesoriere R, Cirillo S, De Rosa G, Ferrero A. Alcohol injection into the portal vein prior to ligation increases liver regeneration rate. HPB (Oxford) 2018;20:739-44. [PMID: 29571617 DOI: 10.1016/j.hpb.2018.02.637] [Reference Citation Analysis]
30 Kambakamba P, Linecker M, Schneider M, Reiner CS, Nguyen-Kim TDL, Limani P, Romic I, Figueras J, Petrowsky H, Clavien PA, Lesurtel M. Impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on growth of colorectal liver metastases. Surgery 2018;163:311-7. [PMID: 29248180 DOI: 10.1016/j.surg.2017.10.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
31 van Lienden KP, Hoekstra LT, van Trigt JD, Roelofs JJ, van Delden OM, van Gulik TM. Effect of hepatic artery embolization on liver hypertrophy response in a rabbit liver VX2 tumor model. Hepatobiliary Pancreat Dis Int 2013;12:622-9. [PMID: 24322748 DOI: 10.1016/s1499-3872(13)60098-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Lim C, Audollent R, Pocard M, Azoulay D. Infusion of CD133+ Bone Marrow–derived Stem Cell After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy. Annals of Surgery 2016;263:e44-5. [DOI: 10.1097/sla.0000000000000404] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Sperling J, Ziemann C, Gittler A, Benz-Weißer A, Menger MD, Kollmar O. Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the mTOR-inhibitor temsirolimus after portal branch ligation. Clin Exp Metastasis 2015;32:313-21. [PMID: 25693517 DOI: 10.1007/s10585-015-9707-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
34 Ironside N, Bell R, Bartlett A, McCall J, Powell J, Pandanaboyana S. Systematic review of perioperative and survival outcomes of liver resections with and without preoperative portal vein embolization for colorectal metastases. HPB (Oxford). 2017;19:559-566. [PMID: 28438427 DOI: 10.1016/j.hpb.2017.03.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
35 Wei N, Wu Z, Lu D, Xiao J, Zhou C, Chu S, Lv W. Expression of MMP-2 in residual VX2 liver tumor after transcatheter arterial embolization combined with portal venous embolization in an animal model. J Interv Med 2020;3:167-73. [PMID: 34805929 DOI: 10.1016/j.jimed.2020.08.006] [Reference Citation Analysis]
36 Hau HM, Tautenhahn H-, Schmelzle M, Morgul HM, Moche M, Bartels M, Uhlmann D. Current strategies for preoperative conditioning of the liver to expand criteria for resectability of hepatic metastases. Eur Surg 2016;48:180-90. [DOI: 10.1007/s10353-015-0381-1] [Reference Citation Analysis]
37 Zou RH, Li AH, Han F, Hong J, Li BK, Huang W, Huang L, Yuan YF. Liver hypertrophy and accelerated growth of implanted tumors in nonembolized liver of rabbit after left portal vein embolization. J Surg Res. 2012;178:255-263. [PMID: 22494913 DOI: 10.1016/j.jss.2012.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
38 Kambakamba P, Hoti E, Cremen S, Braun F, Becker T, Linecker M. The evolution of surgery for colorectal liver metastases: A persistent challenge to improve survival. Surgery 2021:S0039-6060(21)00644-9. [PMID: 34304889 DOI: 10.1016/j.surg.2021.06.033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Riddiough GE, Jalal Q, Perini MV, Majeed AW. Liver regeneration and liver metastasis. Semin Cancer Biol 2021;71:86-97. [PMID: 32532594 DOI: 10.1016/j.semcancer.2020.05.012] [Reference Citation Analysis]
40 Shi H, Yang G, Zheng T, Wang J, Li L, Liang Y, Xie C, Yin D, Sun B, Sun J, Wang H, Pan S, Jiang H, Lau W, Liu L. A preliminary study of ALPPS procedure in a rat model. Sci Rep 2015;5:17567. [PMID: 26631552 DOI: 10.1038/srep17567] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
41 Farach A, Quesada J, Teh BS. Liver regeneration following repeat SBRT. J Gastrointest Oncol 2015;6:E2-6. [PMID: 25830045 DOI: 10.3978/j.issn.2078-6891.2014.082] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Imai K, Yamashita YI, Nakao Y, Uemura N, Kitamura F, Miyata T, Nakagawa S, Okabe H, Hayashi H, Chikamoto A, Ishiko T, Baba H. Is disease progression a contraindication for the strategy of portal vein embolization followed by hepatectomy for hepatocellular carcinoma? Surgery 2019;165:696-702. [PMID: 30467039 DOI: 10.1016/j.surg.2018.10.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
43 Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad KR, Bartlett A, Lodge JP. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery 2015;157:690-8. [DOI: 10.1016/j.surg.2014.12.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 8.3] [Reference Citation Analysis]
44 de Jong KP, Wertenbroek MW. Liver Resection Combined with Local Ablation: Where Are the Limits? Dig Surg 2011;28:127-33. [DOI: 10.1159/000323823] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
45 Robles Campos R, Brusadin R, López Conesa A, Parrilla Paricio P. Staged liver resection for perihilar liver tumors using a tourniquet in the umbilical fissure and sequential portal vein embolization on the fourth postoperative day (a modified ALTPS). Cir Esp. 2014;92:682-686. [PMID: 25151854 DOI: 10.1016/j.ciresp.2014.07.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
46 Denecke T, Seehofer D, Steffen IG, Grieser C, Stelter L, Schnapauff D, Rothe JH, Weigelt A, Pech M, Langrehr J, Podrabsky P, Neuhaus P, Hänninen EL. Arterial Versus Portal Venous Embolization for Induction of Hepatic Hypertrophy before Extended Right Hemihepatectomy in Hilar Cholangiocarcinomas: A Prospective Randomized Study. Journal of Vascular and Interventional Radiology 2011;22:1254-62. [DOI: 10.1016/j.jvir.2011.04.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
47 Cho MS, Kim SH, Park SW, Lim JH, Choi GH, Park JS, Chung JB, Kim KS. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience. J Gastrointest Surg 2012;16:1672-9. [PMID: 22798185 DOI: 10.1007/s11605-012-1960-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
48 De Raffele E, Mirarchi M, Cuicchi D, Lecce F, Ricci C, Casadei R, Cola B, Minni F. Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases. World J Gastrointest Oncol 2018; 10(10): 293-316 [PMID: 30364774 DOI: 10.4251/wjgo.v10.i10.293] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
49 Bennink RJ, Tulchinsky M, de Graaf W, Kadry Z, van Gulik TM. Liver function testing with nuclear medicine techniques is coming of age. Semin Nucl Med 2012;42:124-37. [PMID: 22293167 DOI: 10.1053/j.semnuclmed.2011.10.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
50 Narita M, Oussoultzoglou E, Chenard M, Fuchshuber P, Rosso E, Pessaux P, Jaeck D, Bachellier P. Impact of Biomarkers Expression Before and After Portal Vein Embolization on Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg 2012;16:554-61. [DOI: 10.1007/s11605-011-1732-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
51 Müller PC, Linecker M, Kirimker EO, Oberkofler CE, Clavien PA, Balci D, Petrowsky H. Induction of liver hypertrophy for extended liver surgery and partial liver transplantation: State of the art of parenchyma augmentation-assisted liver surgery. Langenbecks Arch Surg 2021. [PMID: 33740114 DOI: 10.1007/s00423-021-02148-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Simoneau E, Hassanain M, Shaheen M, Aljiffry M, Molla N, Chaudhury P, Anil S, Khashper A, Valenti D, Metrakos P. Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases. Br J Surg. 2015;102:1240-1249. [PMID: 26109487 DOI: 10.1002/bjs.9872] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
53 Hitpass L, Heise D, Schulze-Hagen M, Pedersoli F, Ulmer F, Amygdalos I, Isfort P, Neumann U, Kuhl C, Bruners P, Zimmermann M. Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery. Cancers (Basel) 2020;12:E1638. [PMID: 32575781 DOI: 10.3390/cancers12061638] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Hoekstra LT, van Lienden KP, Schaap FG, Chamuleau RAFM, Bennink RJ, van Gulik TM. Can Plasma Bile Salt, Triglycerides, and apoA-V Levels Predict Liver Regeneration? World J Surg 2012;36:2901-8. [DOI: 10.1007/s00268-012-1770-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
55 Adam R, Hoti E, Bredt LC. Evolution of neoadjuvant therapy for extended hepatic metastases-have we reached our (non-resectable) limit?: Neoadjuvant Therapy. J Surg Oncol 2010;102:922-31. [DOI: 10.1002/jso.21727] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
56 Fülöp A, Szijártó A, Harsányi L, Budai A, Pekli D, Korsós D, Horváth I, Kovács N, Karlinger K, Máthé D, Szigeti K. Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver. PLoS One 2014;9:e90760. [PMID: 24599299 DOI: 10.1371/journal.pone.0090760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
57 Qin XY, Hara M, Arner E, Kawaguchi Y, Inoue I, Tatsukawa H, Furutani Y, Nagatsuma K, Matsuura T, Wei F, Kikuchi J, Sone H, Daub C, Kawaji H, Lassmann T, Itoh M, Suzuki H, Carninci P, Hayashizaki Y, Kokudo N, Forrest ARR, Kojima S; FANTOM consortium. Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes. EBioMedicine 2017;24:257-66. [PMID: 28927749 DOI: 10.1016/j.ebiom.2017.09.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
58 Pommier R, Ronot M, Cauchy F, Gaujoux S, Fuks D, Faivre S, Belghiti J, Vilgrain V. Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: influence of initial response to induction chemotherapy. Ann Surg Oncol. 2014;21:3077-3083. [PMID: 24743912 DOI: 10.1245/s10434-014-3700-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
59 Kikuchi Y, Hiroshima Y, Matsuo K, Murakami T, Kawaguchi D, Endo I, Yamazaki K, Ishida Y, Tanaka K. Remnant Liver Tumor Growth Activity During Treatment Associating Liver Partition and Portal Vein Occlusion for Staged Hepatectomy (ALPPS). J Gastrointest Surg 2017;21:1851-8. [DOI: 10.1007/s11605-017-3523-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
60 Burlaka AA, Paliichuk AV, Iatsyna OI, Kolesnik ОО. Colorectal cancer liver metastases within the central and peripheral segments: Parenchymal sparing surgery adaptation. Ann Med Surg (Lond) 2020;58:8-13. [PMID: 32874570 DOI: 10.1016/j.amsu.2020.07.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, van Delden OM. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36:25-34. [PMID: 22806245 DOI: 10.1007/s00270-012-0440-y] [Cited by in Crossref: 218] [Cited by in F6Publishing: 203] [Article Influence: 21.8] [Reference Citation Analysis]
62 Gabr A, Riaz A, Mouli S, Desai K, Thornburg B, Salem R, Lewandowski RJ. Modified Radiation Lobectomy: An Evolving Paradigm to Convert Patients to Liver Resection Candidacy. Semin Intervent Radiol 2019;36:343-8. [PMID: 31680726 DOI: 10.1055/s-0039-1696648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
63 Belghiti J, Benhaïm L. Portal Vein Occlusion Prior to Extensive Resection in Colorectal Liver Metastasis: A Necessity Rather than an Option! Ann Surg Oncol 2009;16:1098-9. [DOI: 10.1245/s10434-009-0379-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
64 Stavrou GA, Donati M, Ringe KI, Peitgen HO, Oldhafer KJ. Liver remnant hypertrophy induction--how often do we really use it in the time of computer assisted surgery? Adv Med Sci 2012;57:251-8. [PMID: 23314563 DOI: 10.2478/v10039-012-0057-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
65 Iida H, Aihara T, Ikuta S, Yoshie H, Yamanaka N. Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation. World J Gastroenterol 2012; 18(19): 2371-2376 [PMID: 22654428 DOI: 10.3748/wjg.v18.i19.2371] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
66 Fernández-Ros N, Silva N, Bilbao JI, Iñarrairaegui M, Benito A, D'Avola D, Rodriguez M, Rotellar F, Pardo F, Sangro B. Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB (Oxford) 2014;16:243-9. [PMID: 23530966 DOI: 10.1111/hpb.12095] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
67 Lim C, Cauchy F, Azoulay D, Farges O, Ronot M, Pocard M. Tumour progression and liver regeneration--insights from animal models. Nat Rev Gastroenterol Hepatol. 2013;10:452-462. [PMID: 23567217 DOI: 10.1038/nrgastro.2013.55] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
68 Ulmer TF, de Jong C, Andert A, Bruners P, Heidenhain CM, Schoening W, Schmeding M, Neumann UP. ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE). World J Surg. 2017;41:250-257. [PMID: 27464917 DOI: 10.1007/s00268-016-3662-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
69 de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM. Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg. 2011;98:825-834. [PMID: 21484773 DOI: 10.1002/bjs.7456] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 10.3] [Reference Citation Analysis]
70 Ahmed A, Stauffer JA, LeGout JD, Burns J, Croome K, Paz-Fumagalli R, Frey G, Toskich B. The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure. J Gastrointest Oncol 2021;12:751-61. [PMID: 34012663 DOI: 10.21037/jgo-20-507] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Miller FH, Lopes Vendrami C, Gabr A, Horowitz JM, Kelahan LC, Riaz A, Salem R, Lewandowski RJ. Evolution of Radioembolization in Treatment of Hepatocellular Carcinoma: A Pictorial Review. Radiographics 2021;41:1802-18. [PMID: 34559587 DOI: 10.1148/rg.2021210014] [Reference Citation Analysis]
72 Kallini JR, Gabr A, Salem R, Lewandowski RJ. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma. Adv Ther 2016;33:699-714. [PMID: 27039186 DOI: 10.1007/s12325-016-0324-7] [Cited by in Crossref: 82] [Cited by in F6Publishing: 65] [Article Influence: 13.7] [Reference Citation Analysis]
73 Hong YM, Cho M, Yoon KT, Chu CW, Yang KH, Park YM, Rhu JH. Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma. Tumour Biol. 2017;39:1010428317720863. [PMID: 29034775 DOI: 10.1177/1010428317720863] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
74 Lewandowski RJ, Donahue L, Chokechanachaisakul A, Kulik L, Mouli S, Caicedo J, Abecassis M, Fryer J, Salem R, Baker T. (90) Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes. J Surg Oncol. 2016;114:99-105. [PMID: 27103352 DOI: 10.1002/jso.24269] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 9.8] [Reference Citation Analysis]
75 Au KP, Chan ACY. Current status of associating liver partition with portal vein ligation for staged hepatectomy: Comparison with two-stage hepatectomy and strategies for better outcomes. World J Gastroenterol 2019; 25(43): 6373-6385 [PMID: 31798275 DOI: 10.3748/wjg.v25.i43.6373] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Shehta A, Lee JM, Suh KS, Kim HC, Hong SK, Cho JH, Yi NJ, Lee KW. Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg 2020;24:421-30. [PMID: 33234744 DOI: 10.14701/ahbps.2020.24.4.421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
77 de Graaf W, van den Esschert JW, van Lienden KP, Roelofs JJ, van Gulik TM. A Rabbit Model for Selective Portal Vein Embolization. Journal of Surgical Research 2011;171:486-94. [DOI: 10.1016/j.jss.2010.04.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
78 Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 [PMID: 34887643 DOI: 10.3748/wjg.v27.i43.7462] [Reference Citation Analysis]
79 Golse N, Bucur PO, Adam R, Castaing D, Sa Cunha A, Vibert E. New Paradigms in Post-hepatectomy Liver Failure. J Gastrointest Surg 2013;17:593-605. [DOI: 10.1007/s11605-012-2048-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
80 Adam R, Imai K, Castro Benitez C, Allard MA, Vibert E, Sa Cunha A, Cherqui D, Baba H, Castaing D. Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases. Br J Surg. 2016;103:1521-1529. [PMID: 27517369 DOI: 10.1002/bjs.10256] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 9.8] [Reference Citation Analysis]
81 Cieslak KP, Huisman F, Bais T, Bennink RJ, van Lienden KP, Verheij J, Besselink MG, Busch ORC, van Gulik TM. Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization. Surgery. 2017;162:37-47. [PMID: 28365007 DOI: 10.1016/j.surg.2016.12.031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
82 Loos M, Friess H. Is there new hope for patients with marginally resectable liver malignancies. World J Gastrointest Surg 2012; 4(7): 163-165 [PMID: 22905283 DOI: 10.4240/wjgs.v4.i7.163] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
83 Lee EC, Park SJ, Han SS, Park HM, Lee SD, Kim SH, Lee IJ, Kim HB. Mortality after portal vein embolization: Two case reports. Medicine (Baltimore) 2017;96:e5446. [PMID: 28178122 DOI: 10.1097/MD.0000000000005446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
84 Al-Sharif E, Simoneau E, Hassanain M. Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learned. World J Clin Oncol 2015; 6(5): 142-146 [PMID: 26468450 DOI: 10.5306/wjco.v6.i5.142] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
85 Bowers KA, O’Reilly D, Bond-Smith GE, Hutchins RR. Feasibility study of two-stage hepatectomy for bilobar liver metastases. Am J Surg. 2012;203:691-697. [PMID: 22154136 DOI: 10.1016/j.amjsurg.2011.07.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
86 Burgmans MC, Irani FG, Chan WY, Teo TK, Kao YH, Goh AS, Chow PK, Lo RH. Radioembolization After Portal Vein Embolization in a Patient with Multifocal Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2012;Epub ahead of print. [PMID: 22526101 DOI: 10.1007/s00270-012-0376-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
87 Thakrar PD, Madoff DC. Preoperative portal vein embolization: an approach to improve the safety of major hepatic resection. Semin Roentgenol 2011;46:142-53. [PMID: 21338839 DOI: 10.1053/j.ro.2010.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
88 Hahn O, Dudás I, Pajor P, Györke T, Korom C, Zsirka-Klein A, Kupcsulik P, Harsányi L. [ALPPS (Associated Liver Partition and Portal vein ligation for Staged hepatectomy) -- faster and greater growth of liver]. Magy Seb. 2013;66:21-26. [PMID: 23428724 DOI: 10.1556/maseb.66.2013.1.3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]